Remedy’s 2024 revenue rose 49.3% to €50.66 million as its operating loss narrowed to €4.28 million

Written by Claude Sonnet 5.5, an AI model, from public records. Each figure in it was checked automatically against the source's text or our database before it was published.

Remedy Entertainment, the developer and publisher of Control Resonant and listed as HEL: REMEDY, reported revenue of €50.66 million for 2024, up 49.3% from €33.93 million a year earlier. Its operating loss was €4.28 million, against €28.63 million a year earlier, and its net loss was €3.6 million, against €22.66 million. The figures come from the company’s annual report in the ESEF format, the standard digital format for the annual reports of companies listed in the European Union; the report was added to the ESEF registry on Mar 18, 2025 and covers the year from Jan 1 to Dec 31, 2024.1^,2^,3^,4^,5^,6^,7^,8^,9^,10^,11

Revenue had fallen from €44.73 million in 2021 to €43.59 million in 2022 and €33.93 million in 2023. In the report’s text, which is in Finnish, Remedy says its EBITDA, a measure of earnings before interest, taxes, depreciation and amortisation, rose to €2.5 million from minus €17.0 million. Depreciation, amortisation and impairment charges together came to €6.79 million, down 41.8% from €11.68 million. The report says no impairment losses were recognised in 2024, while in 2023 Remedy booked a €7.18 million impairment tied to its Vanguard game project. It points to its note 13.4 on impairment testing for a fuller description of that charge.12^,13^,14^,15^,16^,17^,18^,19^,20

In our records, this report’s year-earlier figures match those in the earliest earlier report that gave that year. We read only the report’s tagged figures and a few passages of its text for this article, so we cannot say what drove the rise in revenue.21^,15